Friday, July 31, 2026

Unlocking the Future: How Neuracle Science’s NS101 is Set to Revolutionize Alzheimer’s Treatment by 2030

Neuracle Science aims for a KOSDAQ listing and focuses on developing NS101 for neurological diseases, attracting global interest.

BIBI’s Controversial Performance at Waterbomb Seoul 2026: Too Risqué for a Music Festival?

BIBI's provocative performance at Waterbomb Seoul 2026 has ignited debate over its suggestive nature and appropriateness for the festival.

Kim Tae-hyo’s Controversial Phone Call: Did He Justify Martial Law to the U.S. Ambassador?

Special prosecutor investigates Kim Tae-hyo for alleged insurrection-related activities post-martial law in South Korea.

Tag: neurodegenerative diseases

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Unlocking the Brain’s Secrets: New Discovery of CSF Drainage Holes Could Revolutionize Alzheimer’s Treatment

A South Korean team discovered openings in the arachnoid membrane that allow cerebrospinal fluid to drain, crucial for brain health.

Neurophet to showcase Alzheimer’s imaging platform at AAIC 2026

Neurophet will showcase its AI-driven brain imaging solutions at AAIC 2026, aiming to partner with global pharmaceutical firms for Alzheimer's treatment.

Can Donanemab Expand Alzheimer’s Treatment to Lewy Body Dementia? Key Insights from Korean Lilly’s Latest Clinical Trials

Lilly has launched a global trial for Kisunla, targeting Lewy body dementia, aiming to expand its Alzheimer's treatment to this underserved area.

Unlocking the Future of Neuroscience: AriBio’s Partnership with Lilly TuneLab for Advanced AI Drug Development

AriBio partners with Eli Lilly's AI platform, Lilly TuneLab, to enhance drug development for neurodegenerative diseases using advanced AI.

SK Biopharmaceuticals Selects Two CNS Startups Through Open Innovation… Advances Expected in Parkinson’s and Alzheimer’s Treatment

SK Biopharmaceuticals partners with Seoul Bio Hub to support two CNS startups, Novorex and Threebrooks, in innovative drug development.

Marriage and Multiple Sclerosis: Study Finds Slower Disease Progression in Married Women

Study shows women with MS experience slower disease progression with a spouse's support, highlighting emotional and physical benefits.

Study Reveals: Taking Statins for 3 Years Can Slash Dementia Risk by 63%!

A study reveals statins can reduce dementia risk by 63%, especially in diabetic patients, highlighting their protective benefits.

When Dreams Turn Violent: The Reality of REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) can cause physical actions during dreams, leading to injuries and potential links to dementia.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.